UiPath Inc.
PATH
$12.07
$0.282.38%
| Weiss Ratings | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.88 | |||
| Price History | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.43% | |||
| 30-Day Total Return | -10.26% | |||
| 60-Day Total Return | -19.26% | |||
| 90-Day Total Return | 0.08% | |||
| Year to Date Total Return | -6.65% | |||
| 1-Year Total Return | -47.95% | |||
| 2-Year Total Return | -20.96% | |||
| 3-Year Total Return | -55.61% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -52.60% | |||
| 52-Week Low % Change | 16.39% | |||
| Price | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $25.47 | |||
| 52-Week Low Price | $10.37 | |||
| 52-Week Low Price (Date) | Aug 05, 2024 | |||
| 52-Week High Price (Date) | Mar 14, 2024 | |||
| Valuation | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.63B | |||
| Enterprise Value | 5.11B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.16 | |||
| Earnings Per Share Growth | -39.59% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.71 | |||
| Price/Book (Q) | 3.83 | |||
| Enterprise Value/Revenue (TTM) | 3.62 | |||
| Price | $12.07 | |||
| Enterprise Value/EBITDA (TTM) | -34.64 | |||
| Enterprise Value/EBIT | -30.90 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 551.04M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 844 432 0455 | |||
| Address | One Vanderbilt Avenue New York, NY 10017 | |||
| Website | www.uipath.com | |||
| Country | United States | |||
| Year Founded | 2005 | |||
| Profitability | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -11.72% | |||
| Profit Margin | -6.48% | |||
| Management Effectiveness | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -3.79% | |||
| Return on Equity | -- | |||
| Income Statement | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.41B | |||
| Total Revenue (TTM) | 1.41B | |||
| Revenue Per Share | $2.56 | |||
| Gross Profit (TTM) | 1.18B | |||
| EBITDA (TTM) | -147.58M | |||
| EBIT (TTM) | -165.44M | |||
| Net Income (TTM) | -91.57M | |||
| Net Income Avl. to Common (TTM) | -91.57M | |||
| Total Revenue Growth (Q YOY) | 8.82% | |||
| Earnings Growth (Q YOY) | 66.21% | |||
| EPS Diluted (TTM) | -0.16 | |||
| EPS Diluted Growth (Q YOY) | 65.29% | |||
| Balance Sheet | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.57B | |||
| Cash Per Share (Q) | $2.85 | |||
| Total Current Assets (Q) | 2.18B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.73B | |||
| Current Ratio (Q) | 3.129 | |||
| Book Value Per Share (Q) | $3.15 | |||
| Total Assets (Q) | 2.66B | |||
| Total Current Liabilities (Q) | 695.47M | |||
| Total Debt (Q) | 81.60M | |||
| Total Liabilities (Q) | 931.45M | |||
| Total Common Equity (Q) | 1.73B | |||
| Cash Flow | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -37.45M | |||
| Cash from Financing (TTM) | -515.45M | |||
| Net Change in Cash (TTM) | -229.46M | |||
| Levered Free Cash Flow (TTM) | 440.47M | |||
| Cash from Operations (TTM) | 320.09M | |||
